Annual Retained Earnings
-$83.86 M
-$20.06 M-31.44%
December 31, 2023
Summary
- As of February 8, 2025, CYTH annual retained earnings is -$83.86 million, with the most recent change of -$20.06 million (-31.44%) on December 31, 2023.
- During the last 3 years, CYTH annual retained earnings has fallen by -$49.79 million (-146.19%).
- CYTH annual retained earnings is now -5629.09% below its all-time high of -$1.46 million, reached on December 31, 2003.
Performance
CYTH Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$103.01 M
-$8.83 M-9.38%
September 30, 2024
Summary
- As of February 8, 2025, CYTH quarterly retained earnings is -$103.01 million, with the most recent change of -$8.83 million (-9.38%) on September 30, 2024.
- Over the past year, CYTH quarterly retained earnings has dropped by -$19.16 million (-22.85%).
- CYTH quarterly retained earnings is now -6937.91% below its all-time high of -$1.46 million, reached on December 31, 2003.
Performance
CYTH Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
CYTH Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.4% | -22.9% |
| 3 y3 years | -146.2% | -22.9% |
| 5 y5 years | -376.8% | -22.9% |
CYTH Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -73.4% | at low | -113.1% | at low |
| 5 y | 5-year | -233.8% | at low | -310.1% | at low |
| alltime | all time | -5629.1% | at low | -6937.9% | at low |
Cyclo Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$103.01 M(+9.4%) |
| Jun 2024 | - | -$94.18 M(+6.8%) |
| Mar 2024 | - | -$88.20 M(+5.2%) |
| Dec 2023 | -$83.86 M(+31.4%) | -$83.86 M(+7.2%) |
| Sep 2023 | - | -$78.21 M(+6.5%) |
| Jun 2023 | - | -$73.44 M(+6.7%) |
| Mar 2023 | - | -$68.81 M(+7.8%) |
| Dec 2022 | -$63.80 M(+32.0%) | -$63.80 M(+8.5%) |
| Sep 2022 | - | -$58.82 M(+7.8%) |
| Jun 2022 | - | -$54.57 M(+6.8%) |
| Mar 2022 | - | -$51.12 M(+5.7%) |
| Dec 2021 | -$48.35 M(+41.9%) | -$48.35 M(+6.1%) |
| Sep 2021 | - | -$45.56 M(+9.3%) |
| Jun 2021 | - | -$41.70 M(+9.4%) |
| Mar 2021 | - | -$38.10 M(+11.9%) |
| Dec 2020 | -$34.06 M(+35.6%) | -$34.06 M(+8.5%) |
| Sep 2020 | - | -$31.38 M(+4.8%) |
| Jun 2020 | - | -$29.95 M(+7.9%) |
| Mar 2020 | - | -$27.75 M(+10.5%) |
| Dec 2019 | -$25.12 M(+42.8%) | -$25.12 M(+11.7%) |
| Sep 2019 | - | -$22.49 M(+7.8%) |
| Jun 2019 | - | -$20.86 M(+7.0%) |
| Mar 2019 | - | -$19.49 M(+10.8%) |
| Dec 2018 | -$17.59 M(+31.9%) | -$17.59 M(+8.4%) |
| Sep 2018 | - | -$16.22 M(+5.1%) |
| Jun 2018 | - | -$15.43 M(+9.1%) |
| Mar 2018 | - | -$14.15 M(+6.1%) |
| Dec 2017 | -$13.33 M(+40.4%) | -$13.33 M(+11.6%) |
| Sep 2017 | - | -$11.95 M(+5.6%) |
| Jun 2017 | - | -$11.31 M(+7.9%) |
| Mar 2017 | - | -$10.49 M(+10.4%) |
| Dec 2016 | -$9.50 M(+80.1%) | -$9.50 M(+9.6%) |
| Sep 2016 | - | -$8.67 M(+22.9%) |
| Jun 2016 | - | -$7.05 M(+17.9%) |
| Mar 2016 | - | -$5.98 M(+13.4%) |
| Dec 2015 | -$5.28 M(+93.6%) | -$5.28 M(+25.0%) |
| Sep 2015 | - | -$4.22 M(+21.5%) |
| Jun 2015 | - | -$3.47 M(+11.6%) |
| Mar 2015 | - | -$3.11 M(+14.3%) |
| Dec 2014 | -$2.72 M(+27.8%) | -$2.72 M(+13.2%) |
| Sep 2014 | - | -$2.41 M(+10.1%) |
| Jun 2014 | - | -$2.19 M(+7.4%) |
| Mar 2014 | - | -$2.03 M(-4.5%) |
| Dec 2013 | -$2.13 M(-8.8%) | -$2.13 M(+4.1%) |
| Sep 2013 | - | -$2.05 M(+4.8%) |
| Jun 2013 | - | -$1.95 M(-11.9%) |
| Mar 2013 | - | -$2.22 M(-5.1%) |
| Dec 2012 | -$2.34 M | -$2.34 M(-5.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | -$2.47 M(+1.9%) |
| Jun 2012 | - | -$2.42 M(+2.4%) |
| Mar 2012 | - | -$2.37 M(-1.9%) |
| Dec 2011 | -$2.41 M(+4.2%) | -$2.41 M(+6.2%) |
| Sep 2011 | - | -$2.27 M(-0.8%) |
| Jun 2011 | - | -$2.29 M(-1.5%) |
| Mar 2011 | - | -$2.32 M(+0.4%) |
| Dec 2010 | -$2.31 M(+1.7%) | -$2.31 M(-2.7%) |
| Sep 2010 | - | -$2.38 M(+1.6%) |
| Jun 2010 | - | -$2.34 M(-1.1%) |
| Mar 2010 | - | -$2.37 M(+4.0%) |
| Dec 2009 | -$2.28 M(+9.3%) | -$2.28 M(+7.7%) |
| Sep 2009 | - | -$2.11 M(-1.5%) |
| Jun 2009 | - | -$2.15 M(+0.5%) |
| Mar 2009 | - | -$2.14 M(+2.5%) |
| Dec 2008 | -$2.08 M(+24.8%) | -$2.08 M(+19.4%) |
| Sep 2008 | - | -$1.74 M(-0.1%) |
| Jun 2008 | - | -$1.75 M(+0.5%) |
| Mar 2008 | - | -$1.74 M(+4.0%) |
| Dec 2007 | -$1.67 M(-28.1%) | -$1.67 M(-22.9%) |
| Sep 2007 | - | -$2.16 M(-3.1%) |
| Jun 2007 | - | -$2.23 M(-3.7%) |
| Mar 2007 | - | -$2.32 M(-0.1%) |
| Dec 2006 | -$2.32 M(+4.6%) | -$2.32 M(+0.0%) |
| Sep 2006 | - | -$2.32 M(+2.8%) |
| Jun 2006 | - | -$2.26 M(+0.9%) |
| Mar 2006 | - | -$2.24 M(+0.9%) |
| Dec 2005 | -$2.22 M(+8.4%) | -$2.22 M(+16.8%) |
| Sep 2005 | - | -$1.90 M(+4.1%) |
| Jun 2005 | - | -$1.83 M(-1.2%) |
| Mar 2005 | - | -$1.85 M(-9.8%) |
| Dec 2004 | -$2.05 M(+39.9%) | -$2.05 M(+13.6%) |
| Sep 2004 | - | -$1.80 M(-0.6%) |
| Jun 2004 | - | -$1.81 M(+23.3%) |
| Mar 2004 | - | -$1.47 M(+0.5%) |
| Dec 2003 | -$1.46 M(-16.8%) | -$1.46 M(-15.0%) |
| Sep 2003 | - | -$1.72 M(-1.6%) |
| Jun 2003 | - | -$1.75 M(-1.2%) |
| Mar 2003 | - | -$1.77 M(+0.6%) |
| Dec 2002 | -$1.76 M(-8.6%) | -$1.76 M(+1.7%) |
| Sep 2002 | - | -$1.73 M(-4.9%) |
| Jun 2002 | - | -$1.82 M(-2.8%) |
| Mar 2002 | - | -$1.87 M(-2.8%) |
| Dec 2001 | -$1.92 M(+6.3%) | -$1.92 M(+1.8%) |
| Sep 2001 | - | -$1.89 M(+2.9%) |
| Jun 2001 | - | -$1.84 M(0.0%) |
| Mar 2001 | - | -$1.84 M(+1.5%) |
| Dec 2000 | -$1.81 M | -$1.81 M(+20.4%) |
| Sep 2000 | - | -$1.50 M |
FAQ
- What is Cyclo Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Cyclo Therapeutics?
- What is Cyclo Therapeutics annual retained earnings year-on-year change?
- What is Cyclo Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Cyclo Therapeutics?
- What is Cyclo Therapeutics quarterly retained earnings year-on-year change?
What is Cyclo Therapeutics annual retained earnings?
The current annual retained earnings of CYTH is -$83.86 M
What is the all time high annual retained earnings for Cyclo Therapeutics?
Cyclo Therapeutics all-time high annual retained earnings is -$1.46 M
What is Cyclo Therapeutics annual retained earnings year-on-year change?
Over the past year, CYTH annual retained earnings has changed by -$20.06 M (-31.44%)
What is Cyclo Therapeutics quarterly retained earnings?
The current quarterly retained earnings of CYTH is -$103.01 M
What is the all time high quarterly retained earnings for Cyclo Therapeutics?
Cyclo Therapeutics all-time high quarterly retained earnings is -$1.46 M
What is Cyclo Therapeutics quarterly retained earnings year-on-year change?
Over the past year, CYTH quarterly retained earnings has changed by -$19.16 M (-22.85%)